Expression ofNUP98/TOP1, but not ofTOP1/NUP98, in a treatment-related myelodysplastic syndrome with t(10;20;11)(q24;q11;p15)
- 26 February 2002
- journal article
- case report
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 34 (2) , 249-254
- https://doi.org/10.1002/gcc.10066
Abstract
The t(11;20)(p15;q11) is a rare but recurrent translocation that so far has been described in only four acute myeloid leukemias (AMLs), two treatment-related myelodysplastic syndromes (t-MDSs), and one case of polycythemia vera. Recently, the t(11;20) was shown to result in a fusion of the NUP98 and TOP1 genes, with expression of the NUP98/TOP1 chimera encoded by the der(11)t(11;20), but not of the reciprocal TOP1/NUP98 on the der(20)t(11;20). The genomic breakpoints were subsequently mapped to introns 13 and 7 of NUP98 and TOP1, respectively. We present here a t-MDS with a three-way variant translocation, t(10;20;11)(q24;q11;p15), that generates a der(11)t(11;20) but not a der(20)t(11;20), strongly suggesting that the der(11) harbors the critical genetic rearrangement. Reverse transcriptase-polymerase chain reaction (RT-PCR) revealed a NUP98/TOP1 fusion in which exon 13 of NUP98 was fused in-frame with exon 8 of TOP1. Extra long (XL) genomic PCR and subsequent sequence analyses showed that the breakpoint in NUP98 occurred at nucleotide (nt) 3461 of intron 13, close to a MER (medium reiteration frequency interspersed repetitive element) repeat, and that the breakpoint in TOP1 was at nt 1436 of intron 7, downstream of a MIR (mammalian-wide interspersed repeats) repetitive element. Genomic XL PCR did not amplify the reciprocal TOP1/NUP98, nor was this chimera expressed, as expected from the cytogenetic finding. The present results provide further support for the involvement of the NUP98/TOP1 transcript, but not of the reciprocal one, in the development of MDS/AML. Furthermore, the three cases genomically characterized to date have all been treatment-related and have all harbored breakpoints in intron 13 of NUP98 and intron 7 of TOP1, suggesting that these introns are susceptible to chemotherapy-induced breakageKeywords
Funding Information
- Swedish Cancer Society
- Medical Faculty of Lund University, Sweden
This publication has 13 references indexed in Scilit:
- A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemiaBlood, 2001
- RET Rearrangements in Radiation-Induced Papillary Thyroid Carcinomas: High Prevalence of Topoisomerase I Sites at Breakpoints and Microhomology-Mediated End Joining in ELE1 and RET Chimeric GenesGenomics, 2001
- Potential role for DNA topoisomerase II poisons in the generation of t(11;20)(p15;q11) translocationsGenes, Chromosomes and Cancer, 2000
- The t(11;20)(p15;q11) Chromosomal Translocation Associated With Therapy-Related Myelodysplastic Syndrome Results in anNUP98-TOP1 FusionBlood, 1999
- The (4;11)(q21;p15) Translocation Fuses the NUP98 andRAP1GDS1 Genes and Is Recurrent in T-Cell Acute Lymphocytic LeukemiaBlood, 1999
- Low frequency of rearrangements of the homeobox geneHOXA9/t(7;11) in adult acute myeloid leukemiaGenes, Chromosomes and Cancer, 1999
- Association of CYP 3 A 4 genotype with treatment-related leukemiaProceedings of the National Academy of Sciences, 1998
- A Further Case of a t(11;20)(p15;q11.2) Translocation in an Acute Myeloid Leukemia (FAB M2)Journal of Pediatric Hematology/Oncology, 1998
- The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP96 and class I homeoprotein HOXA9Nature Genetics, 1996
- Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemiaNature Genetics, 1996